What does Cardio Diagnostics do?

Cardio Diagnostics Inc., based in Chicago, Illinois, is a biotechnology and medical technology company dedicated to improving cardiovascular disease prevention, early detection, and monitoring. The company utilizes AI-driven genetic-epigenetic testing and cloud-based remote patient monitoring solutions to make these services more accessible and personalized. The flagship product, EpiGen CHD, is a blood-based DNA test that assesses the risk of coronary heart disease, providing actionable insights through AI analysis. Additionally, Cardio Diagnostics offers remote patient monitoring solutions, including the CardioConnect Mobile App and CloudBeat RPM Web Application, which facilitate chronic condition management and enhance provider-patient connectivity. The company's proprietary Core Technology combines genetic and epigenetic data to support prevention and treatment in cardiovascular health.